A Study of Subcutaneous Gefurulimab Using Prefilled Syringe Versus Autoinjector in Healthy Adult Participants
Clinical trial NCT06208488 · COMPLETED
Trial details
- NCT number
- NCT06208488
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-22
- Primary completion
- 2024-09-17
- Enrollment
- 175
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.